AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma
- Status
- COMPLETED
- Phase
- NA
A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
- Status
- COMPLETED
- Phase
- PHASE2
Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot Study
- Status
- UNKNOWN
- Phase
- NA
Open Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment
- Status
- COMPLETED
- Phase
- PHASE2